July 22 (UPI) -- The biopharmaceutical company AstraZeneca announced it will $50 billion into the United States, with plans to open several manufacturing facilities in several states. AstraZeneca said in a press release Monday that it will invest by both manufacturing some of its medicines and conducting research and development stateside, and will reach that $50 billion mark by 2030. This move is intended to create thousands of new American jobs, with the main effort to expand being a multi-